Glucosamine: A potential disease-modifying agent in osteoarthritis?
AUTOR(ES)
Chen, Benjamin H.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=81264Documentos Relacionados
- Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
- Evidence for early disease-modifying drugs in rheumatoid arthritis
- Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease
- Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
- Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes